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Spacer-free BODIPY ﬂuorogens in antimicrobial
peptides for direct imaging of fungal infection in
human tissue
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Fluorescent antimicrobial peptides are promising structures for in situ, real-time imaging of
fungal infection. Here we report a ﬂuorogenic probe to image Aspergillus fumigatus directly in
human pulmonary tissue. We have developed a ﬂuorogenic Trp-BODIPY amino acid with a
spacer-free C-C linkage between Trp and a BODIPY ﬂuorogen, which shows remarkable
ﬂuorescence enhancement in hydrophobic microenvironments. The incorporation of our
ﬂuorogenic amino acid in short antimicrobial peptides does not impair their selectivity for
fungal cells, and enables rapid and direct fungal imaging without any washing steps. We have
optimized the stability of our probes in human samples to perform multi-photon imaging of
A. fumigatus in ex vivo human tissue. The incorporation of our unique BODIPY ﬂuorogen in
biologically relevant peptides will accelerate the development of novel imaging probes with
high sensitivity and speciﬁcity.
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I
nvasive pulmonary aspergillosis (IPA) is a highly fatal disease
in immunocompromised patients. IPA results from the
infection with the fungal pathogen Aspergillus fumigatus,
and it is a frequent cause of fungal pneumonia with mortality
rates up to 40% (ref. 1). Current diagnostic approaches for IPA
rely on histological analysis, cultures from bronchoalveolar lavage
ﬂuid and sampling peripheral blood2. These methods are fraught
with problems of upper airway contamination and diagnostic
delays, by which time the disease may have progressed or been
treated empirically with inappropriate drugs. Moreover, blood
markers are unlikely to provide useful information about events
deep in pulmonary tissue, especially in patients with multi-system
disease, such as immunosuppressed patients affected by IPA.
These limitations of current diagnostic tools have prompted the
development of imaging probes that can provide in situ and real-
time information on the progression of infection3–6. Fluorescent
probes based on antibiotics and antimicrobial peptides are
chemical entities with enormous potential for imaging infection
sites due to their high selectivity for microbial cell structures over
mammalian cells7–11. van Oosten et al.12 recently reported a
near-infrared ﬂuorescently labelled vancomycin for real-time
in vivo imaging of bacterial infections in a mouse myocitis model.
Similarly, Thiberville and co-workers have described
ﬂuorescein-conjugated peptides to visualize fungal bioﬁlms in
immunosupressed rats using ﬁbre-based microendoscopy13.
These probes have been prepared by conjugating peptides of
interest to suitable ﬂuorophores via chemical spacers. While such
approaches have been useful to functionalise long peptides or
proteins14, alternative strategies are needed for shorter peptides,
where relevant modiﬁcations can compromise their speciﬁcity.
Our group and others have studied the mechanism of action of
Peptide AntiFungal 26 (PAF26), a synthetic antimicrobial
hexapeptide with high afﬁnity for fungal cells and selectivity
over bacterial and mammalian cells15,16. We envisaged that
ﬂuorescent analogues of PAF26 would enable imaging of fungal
infection sites provided that the main recognition features of
PAF26 remained unaffected after labelling. However, the
incorporation of ﬂuorophores in short antimicrobial peptides is
challenging as chemical modiﬁcations are likely to alter the
distribution of positive charges as well as their amphipathic
character. PAF26 has a highly conserved sequence with a
C-terminal hydrophobic domain (Trp–Phe–Trp) and an
N-terminal cationic domain (Arg–Lys–Lys) that are essential
to exert its antifungal action. Site-speciﬁc peptide labelling
can be achieved by incorporation of amino acids with bio-
orthogonal17–20 or ﬂuorogenic groups21–23. Fluorogenic amino
acids are advantageous in that they provide high signal-to-noise
ratios without the need for washing or additional labelling steps.
A number of ﬂuorogenic amino acids have been reported24–26,
but most exhibit inherent limitations as ﬂuorophores
(for example, short emission wavelengths, low extinction
coefﬁcients and compromised cell permeability). We have
developed a spacer-free ﬂuorogenic amino acid based on the
4,4-diﬂuoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) scaffold,
and incorporated it in the hydrophobic domain of PAF26 to
maintain the recognition features of the peptide while providing
an excellent reporter of the interaction with fungal cells. This
innovative approach has rendered ﬂuorogenic BODIPY-labelled
antimicrobial peptides as highly stable probes to image
A. fumigatus directly in ex vivo human tissue.
Results
Design and synthesis of a Trp-BODIPY ﬂuorogenic amino acid.
BODIPY is a ﬂuorescent structure with excellent cell
permeability and photophysical properties27,28. Moreover, the
BODIPY scaffold can be derivatized with radioisotopes to prepare
multimodal agents for both optical imaging and positron
emission tomography29,30, enabling quantitative whole-body
imaging with high sensitivity31,32. Multimodal agents, which are
designed to be compatible with complementary imaging
modalities, are excellent tools to achieve good spatial resolution
and speciﬁcity without compromising high sensitivity33. Despite
the numerous BODIPY derivatives described to date34–38, there
are no reports of BODIPY-based ﬂuorogenic amino acids.
Environmentally sensitive ﬂuorogens can be prepared by direct
conjugation of the BODIPY core to electron-rich groups leading
to photo-induced electron transfer quenching39–41. We envisaged
that the direct coupling of the indole group of Trp to the BODIPY
core would render a ﬂuorogenic amino acid with potential to
replace Trp in the preparation of ﬂuorogenic antimicrobial
peptides. Our group has recently described some Pd-catalysed
C-H activation42–44 as an efﬁcient way to arylate the indole C2
position45 of Trp and prepare Trp-derivatized peptides and
peptidomimetics46–48. In this way, we synthesized two BODIPY
iodide derivatives (1 and 2, Fig. 1a) in good yields using our
recently developed procedures and assessed their reactivity in
Pd-catalysed C2-arylation of Fmoc-Trp-OH. Notably, only the
conjugate 3 was obtained from the m-iodophenyl-BODIPY (2)49,
while the corresponding p-iodophenyl 1 was unreactive, reﬂecting
electronic preferences (Fig. 1a and Supplementary Discussion).
We further optimized the gram-scale synthesis of 3 using
microwave-assisted irradiation to readily isolate the ﬂuorogenic
amino acid as a solid stable compound with 74% yield,
suitably protected to be directly used in solid-phase peptide
synthesis (SPPS).
Synthesis and evaluation of ﬂuorogenic antifungal peptides.
The amino acid 3 displayed characteristic absorption and
emission wavelengths of BODIPY probes as well as very high
extinction coefﬁcients (Fig. 1a, Supplementary Figs 1,2). Next we
evaluated the properties of 3 as a ﬂuorogenic probe and its
potential to report interactions of antimicrobial peptides with
fungal cells. Many antimicrobial peptides, including PAF26,
recognize molecular components of the microbial cell membrane
and accumulate in lipophilic intracellular compartments.
Therefore, we examined the ﬂuorescence spectra of 3 in phos-
pholipid bilayer membranes that mimic such microenvironments.
As shown in Fig. 1b, the BODIPY core embedded in 3 displayed
remarkable ﬂuorogenic behaviour with strong ﬂuorescence
emission upon binding to phospholipid membranes. In view of
the properties of 3 as a ﬂuorogenic surrogate of Trp, we prepared
ﬂuorogenic derivatives of PAF26 by SPPS. Since the sequence of
PAF26 (4, Fig. 2a) contains two Trp residues, we synthesized all
three possible combinations (5–7, Fig. 2a) to assess the impact of
the amino acid 3 at different positions of the antimicrobial
peptide. The amino acid 3 proved to be fully compatible with
SPPS as it tolerates standard Fmoc deprotection and coupling
conditions as well as mildly acidic (that is, 1% triﬂuoroacetic acid)
cleavage cocktails for acid-labile solid supports (for example,
Sieber amide and chlorotrityl-based polystyrene resins) without
observing any degradation (Supplementary Methods and
Supplementary Fig. 20). Being mildly acidic conditions harmless
to the BODIPY core50, peptides 5–7 were prepared using
conventional SPPS protocols in a Sieber amide polystyrene
resin. Molecular simulation models of both labelled and
non-labelled peptides corroborated that the introduction of
BODIPY scaffolds in the hydrophobic domain of PAF26 did
not disrupt the conformation and hydrogen bonding pattern of
the original peptide (Supplementary Fig. 3). Next we determined
the activity of the peptides 4–7 in A. fumigatus as well as in
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bacterial strains and human RBCs as an indication of their
afﬁnity for both microbial and human cells. We included
Klebsiella pneumoniae, Escherichia coli and Pseudomonas
aeruginosa as clinically relevant bacterial strains commonly
found in hospitalized pulmonary infections51. Likewise, we
tested the activity of 4–7 in human RBCs, because positively
charged peptides are potential haemolytic agents52. Remarkably,
the incorporation of 3 in the hydrophobic domain of PAF26
rendered peptides (5–7) with slightly higher afﬁnity for
A. fumigatus than the non-labelled PAF26 peptide (4) (Fig. 2b
and Supplementary Fig. 4). The marginal activity of PAF26 in
bacterial and human cells was also maintained in all ﬂuorogenic
analogues (Fig. 2b, Supplementary Figs 5,6). Altogether, these
results validate the direct C-C conjugation of BODIPY ﬂuorogens
to the C2 position of the indole ring of Trp as a novel labelling
approach with minimal interference in the molecular recognition
properties of PAF26 while providing a suitable tag to report the
interaction with A. fumigatus.
Imaging Aspergillus fumigatus in co-culture with human cells.
Peptides 5–7 exhibited similar spectral properties to 3 with an
equally strong ﬂuorogenic behaviour in phospholipid membranes
(Fig. 2c and Supplementary Fig. 7). Double-labelled peptide 7
displayed a weaker ﬂuorescence response than mono-labelled
peptides (5, 6), partially due to the self-quenching derived from
two neighbouring BODIPY ﬂuorophores. In view of the excellent
properties of 5-7 as fungi-targeting ﬂuorogenic peptides, we
evaluated them as live cell imaging agents of A. fumigatus.
Peptides 5 and 6 brightly stained fungal cells, whereas 7 showed
signiﬁcantly weaker ﬂuorescence, in accordance with its lower
ﬂuorogenicity (Fig. 2c). As negative controls, we assessed the
activity and imaging properties of ﬂuorogenic derivatives of
PAF26 replacing some of the key residues for their interaction
with fungal cells53. Peptide 5a, which lacks the hydrophilic
domain of PAF26, showed poor activity and staining in
A. fumigatus (Supplementary Fig. 8). Similar results were
obtained when we examined the activity and staining properties
of the single BODIPY amino acid 3 (Supplementary Fig. 8).
We also synthesized peptide 5b, including less non-polar residues
in the hydrophobic domain, which exhibited reduced activity
and brightness in A. fumigatus (Supplementary Fig. 8).
These observations conﬁrmed the importance of embedding
the amino acid 3 within the full amphipathic sequence of
PAF26 in order to efﬁciently interact with the cell membrane of
A. fumigatus.
We further used peptide 5 to image live A. fumigatus in
co-cultures with human lung epithelial cells. As shown in Fig. 2d,
the ﬂuorogenic properties of 5 enabled direct live fungal cell
imaging without the need of any washing steps. Furthermore, we
counterstained lung epithelial cells with the red ﬂuorescent dye
Syto82 and performed plot proﬁle analysis to conﬁrm that 5
speciﬁcally labelled A. fumigatus without staining human lung
epithelial cells (Fig. 2d).
Probe optimization for direct ex vivo tissue imaging. Direct
tissue imaging of infection sites is often hampered by the high
concentration of proteolytic enzymes54, which can compromise
the integrity of imaging agents. Hence, we decided to examine the
chemical stability of peptide 5 in human bronchoalveolar lavages
from patients with acute respiratory dystress syndrome to assess
the potential for ex vivo human tissue imaging. The linear peptide
5 was rapidly degraded in human lavages with a half-life shorter
than 60min (Fig. 3a, Supplementary Figs 9,10). To enhance the
stability required for direct ex vivo imaging in human pulmonary
tissue, we synthesized 8 as the corresponding BODIPY-labelled
cyclic analogue (Fig. 3b). Cyclic peptides do not contain free
N- and C-terminal groups, leading to increased resistance to
degradation by proteases55,56. We synthesized compound 8 using
2-chlorotrityl polystyrene resin, which enabled the preparation
and subsequent cleavage of the protected linear peptide under
mild acidic conditions (Supplementary Fig. 11). Head-to-tail
cyclization was performed in solution with 87% yield using
HATU as the coupling reagent. We optimized the reaction
conditions to remove all the protecting groups without affecting
the BODIPY scaffold. Reduction of the protected peptide in H2
atmosphere with Pd(OH)2/C using mild acidic conditions led to
the desired product with yields around 60% and purities over
90%. The peptide 8 showed around two-fold enhanced afﬁnity for
fungal cells compared with peptide 5, and maintained very high
selectivity over bacteria and human cells (Fig. 2b). A similar
activity proﬁle was observed for peptide 9, the non-labelled
analogue of peptide 8 (Supplementary Fig. 8). Peptide 9 showed
slightly enhanced afﬁnity for A. fumigatus when compared with
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the linear PAF26 sequence (4), and maintained high selectivity
over bacteria and human RBCs (Supplementary Fig. 8). These
observations are in line with the fact that peptide cyclization can
restrict conformational ﬂexibity, which often leads to enhanced
afﬁnity and activity57. Preliminar NMR analysis of 8 showed no
evidence of relevant structural modiﬁcations with respect to the
non-labelled peptide 9, in agreement with molecular simulations
(Supplementary Fig. 3). Importantly, the peptide 8 remained
intact after 24 h in human bronchoalveolar lavages from patients
with acute respiratory dystress syndrome (Fig. 3a, Supplementary
Figs 9,10). The peptide 8 also displayed stronger ﬂuorogenic
response than the linear peptides (5,6) and remarkable
ﬂuorescence emission in phospholipid membranes with
quantum yields reaching 30% (Supplementary Figs 12,13). In
addition to A. fumigatus, we examined the ability of peptide 8 to
stain different fungal strains (Supplementary Fig. 14). While we
observed slight differences in ﬂuorescence intensity between
strains, peptide 8 stained most fungal cells, indicating its potential
as a probe for imaging fungal infection sites of variable origin. We
also employed 8 to image A. fumigatus that had been pre-treated
or not with an excess of non-labelled PAF26 (4) (Supplementary
Fig. 15 and Supplementary Movies 1,2). Cells that were
pre-treated with compound 4 showed signiﬁcantly lower
staining when exposed to the same concentration of peptide 8,
conﬁrming the speciﬁcity of our ﬂuorogenic cyclic structure. We
also conﬁmed that the peptide 8 brightly stained A. fumigatus in
co-cultures with human lung epithelial cells (Supplementary
Fig. 16). All these observations assert the cyclic peptide 8 as a
ﬂuorogenic probe with high stability in lavage samples from
patients with multi-system respiratory disease and potential for
direct ex vivo imaging of A. fumigatus in human pulmonary
tissue.
Ex vivo imaging of Aspergillus fumigatus in human tissue. Next
we employed the peptide 8 for high-resolution imaging of
A. fumigatus. Time-lapse imaging showed the ﬂuorogenic
response of 8 upon interaction with the fungal cell membrane and
after being internalized and accumulated in lipid-rich
intracellular compartments (Fig. 3d and Supplementary Movie 3).
The kinetic analysis shows that the peptide 8 labelled fungal cells
very rapidly, within few minutes after addition of the probe and
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without requiring any washing steps (Fig. 3c). Moreover, the
peptide 8 showed no cytotoxicity in lung epithelial cells, even at
high concentrations (Supplementary Fig. 17). In view of these
properties, we employed the peptide 8 for direct imaging of
A. fumigatus in human pulmonary tissue using multi-photon
microscopy. In order to conﬁrm the speciﬁc staning of 8, we
employed a transgenic strain of A. fumigatus expressing red
ﬂuorescent protein (RFP) in the cytoplasm. As shown in Fig. 4a,
Time
(h)
Linear
(5)
Cyclic
(8)
1 49% 99%
1.00
0.75
0.50
0.25
N
or
m
al
iz
ed
 fl
uo
re
sc
en
ce
0.00
0 240 480
Time (s)
720
3 2% 99%
24 <1% 95%
a b c
d
(i ) (ii ) (iii ) (iv )
NH
NH NH
H
N
NHHNHN
H
N
HN
H2N O
O
O O
O
O
H2N
NH2
N
H
O
NH
N B
N
F F
+
–
8
Figure 3 | The cyclic peptide 8 is a highly stable ﬂuorogenic agent for high-resolution imaging of A. fumigatus. (a) Comparative chemical stability of
mono-labelled BODIPY linear (5) and cyclic (8) PAF26 analogues in human bronchoalveolar lavage samples from patients with acute respiratory distress
syndrome. (b) Chemical structure of the cyclic BODIPY-labelled peptide 8. (c) Kinetic analysis (from time-lapse imaging in d of the ﬂuorescence signal of
compound 8 (2mM) in the cell membrane of A. fumigatus (arrow points at the addition time for compound 8). (d) Time-lapse high-resolution imaging of A.
fumigatus upon incubation with a cell membrane counterstain (red) and compound 8 (2mM, green) for 0min (i), 1min (ii), 3min (iii) and 10min (iv) (see
Supplementary Movie 3). Scale bar, 2.5mm.
BA A
C B
a
Average lifetime
3.5 ns
2.5 ns
b
D
Figure 4 | Multi-photon ﬂuorescence microscopy of ex vivo human pulmonary tissue after incubation with RFP-expressing A. fumigatus. (a) Multi-
photon microscope images from peptide 8 (5mM) (A), RFP-expressing A. fumigatus (B), second harmonic generation from collagen ﬁbres (C) and merged
(D) in ex vivo human lung tissue. Scale bar, 10mm. (b) (A) Fluorescence lifetime image of 8-stained A. fumigatus in ex vivo human lung tissue. White arrows
point autoﬂuorescent tissue structures and yellow arrows point 8-stained fungal cells. (B) Corresponding ﬂuorescence image of 8-stained A. fumigatus
(green) and collagen ﬁbres (second harmonic generation, cyan) for the ﬂuorescence lifetime image in A. Scale bar, 20 mm.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10940 ARTICLE
NATURE COMMUNICATIONS | 7:10940 | DOI: 10.1038/ncomms10940 |www.nature.com/naturecommunications 5
the peptide 8 (green) clearly stained RFP-expressing A. fumigatus
(red), which conﬁrmed the selectivity of our probe. Multi-photon
excitation enabled the acquisition of second harmonic generation
(cyan) from the collagen structures of the ﬁbrilar network
of human pulmonary tissue. Furthermore, the examination of
these samples by ﬂuorescence lifetime imaging revealed that
autoﬂuorescent human tissue structures (for example, collagen
and elastin)58, which could potentially overlap with the emission
of BODIPY ﬂuorogens, are readily distinguished from 8-stained
A. fumigatus by their ﬂuorescence lifetimes (Fig. 4b). Altogether,
these results validate our ﬂuorogenic BODIPY-labelled cyclic
peptide 8 as a highly stable imaging agent for direct and
straightforward visualization of A. fumigatus in human tissue.
Discussion
Peptides are excellent scaffolds for the development of imaging
agents due to the highly speciﬁc molecular interactions with their
respective targets. Since most peptides do not contain chemical
groups that enable their direct visualization, they often need to be
modiﬁed with reporters (for example, ﬂuorophores) or reactive
groups (for example, aldehydes, azides, alkynes and tetrazines) for
further derivatization59. Unnatural amino acids containing bio-
orthogonal tags can be incorporated at speciﬁc sites of peptide
sequences by SPPS60. Likewise, the incorporation of genetically
encoded unnatural amino acids in response to nonsense or
frameshift codons has opened the possibility to synthesize protein
and peptide structures with reactive groups for subsequent
modiﬁcation61. Bio-orthogonal approaches typically involve
two-step labelling processes including a conjugation reaction
(for example, ‘click’ chemistry) followed by the removal of excess
labelling agent. Recent advances in bio-orthogonal chemistry
have led to ﬂuorogenic labelling agents that emit a signal only
after conjugation, thus reducing background ﬂuorescence and
washing steps62,63. Alternatively, and most commonly, peptides
are derivatized by incorporation of ﬂuorophores into their
sequence so they can be directly used for imaging. Since
ﬂuorophores are typically bulkier structures, it is imperative
that they are introduced at speciﬁc positions of the sequence
without impairing the molecular recognition properties of the
peptide. Many conjugation methods to attach ﬂuorophores to
peptides involve a chemical spacer and rely on the reactivity of
polar groups (that is, amines, carboxylic acids, thiols, alcohols);
however, these modiﬁcations often disrupt the hydrogen bonding
pattern of the original peptide, having a detrimental effect on its
biological properties.
In the present work, we have engineered a methodology to
prepare ﬂuorogenic peptides that relies on a unique Trp-BODIPY
derivative (3, Fig. 1), which mimics the molecular interactions of
the native Trp. The incorporation of a BODIPY group into the C2
position of Trp via a spacer-free C-C linkage does not affect the
conformation and molecular interactions of the native amino
acid, and introduces a ﬂuorogenic tag that emits only in
hydrophobic environments (Fig. 1). To assess the compatibility
of our approach with SPPS and validate its utility to prepare
peptide-based agents for imaging of fungal infection, we
derivatized the antimicrobial hexapeptide PAF26, which shows
high afﬁnity for the membrane of fungal cells. PAF26 is
an amphipathic peptide with highly conserved C-terminal
hydrophobic and N-terminal cationic domains that are essential
to exert its antifungal action16. Therefore, the derivatization of
PAF26 is not straightforward since conventional labelling might
alter the distribution of positive charges or its amphipathic
character, resulting in a loss of activity and selectivity.
Analogues of PAF26 incorporating the ﬂuorogenic amino acid
3 at speciﬁc sites in their sequence were prepared by SPPS and
showed no impairment of the afﬁnity and selectivity of the
original peptide for fungal cells (Fig. 2). Our ﬂuorogenic peptides
were used for real-time imaging of several fungal pathogens,
namely Fusarium oxysporum, Candida albicans, Cryptococcus
neoformans and A. fumigatus, suggesting a potential common
target for different fungal strains (Supplementary Fig. 14). Given
that A. fumigatus is the fungal pathogen responsible for IPA, a
highly fatal disease in immunocompromised patients, we focused
our imaging studies in this fungal strain.
Notably, the minimal ﬂuorescence background in aqueous
media and strong ﬂuorogenic behaviour of our probes enabled
their use for direct and wash-free imaging of A. fumigatus (Fig. 2).
Competition experiments with the corresponding non-labelled
analogues and comparative studies with non-antifungal
negative controls—lacking key residues for the interaction at
fungal cells—conﬁrmed the speciﬁcity of our PAF26-derived
ﬂuorogenic peptides (Supplementary Figs 8,15).
A major advantage of our methodology is its wide applicability
to bioconjugation and peptide chemistry. The ﬂuorogenic amino
acid 3 and its peptide derivatives are compatible with most
Fmoc-based SPPS protocols as they tolerate standard
deprotection and coupling conditions as well as mildly acidic
(that is, 1% triﬂuoroacetic acid) cleavage cocktails without
observing any degradation. Whereas the precise impact of the
amino acid 3 in the molecular recognition properties of labelled
sequences needs to be examined on a case-by-case basis, we
observed similar activities for labelled and non-labelled peptides
in a relatively broad range of short antimicrobial sequences,
which conﬁrms the ability of the Trp-BODIPY amino acid 3 to
behave as a Trp surrogate (Fig. 2 and Supplementary Fig. 8).
With these peptides being promising imaging agents for in situ
detection of fungal pathogens in clinically relevant samples, we
optimized their chemical stability to image A. fumigatus in ex vivo
human pulmonary tissue. Our optimization studies yielded
peptide 8 as a highly ﬂuorogenic cyclic structure with bright
ﬂuorescence emission in fungal cells and excellent chemical
integrity in samples with high proteolytic activity (Fig. 3 and
Supplementary Figs 9,16). The excellent properties of 8 enabled
its use in multi-photon and lifetime imaging for the direct
visualization of A. fumigatus in ex vivo human tissue and its
discrimination from autoﬂuorescent tissue structures (Fig. 4).
Given that the ﬂuorogenic amino acid 3 can be readily
incorporated and has general applicability to both linear and
cyclic peptides, we envisage that the introduction of our
spacer-free BODIPY ﬂuorogen in relevant peptides will become
a transformative methodology to develop peptide-based imaging
probes with high sensitivity and speciﬁcity. Furthermore, the
extension of our methodology to other aromatic amino acids will
create numerous opportunities for minimally invasive peptide
tagging using synthetically available building blocks.
Methods
Chemical synthesis and characterization. Synthetic procedures and chemical
characterization (NMR and high-performance liquid chromatography analysis) for
all the probes are included in the Supplementary Information (Supplementary
Figs 18–25).
In vitro spectral measurements. Spectroscopic and quantum yield data were
recorded on a Synergy HT spectrophotometer (Biotek). Compounds were dissolved
at the indicated concentrations and spectra were recorded at room temperature.
Spectra are represented as means from at least two independent experiments with
n¼ 3. Quantum yields were calculated by measuring the integrated emission area
of the ﬂuorescence spectra and comparing it to the area measured for ﬂuorescein in
basic ethanol as reference (QY: 0.97). Phosphatidylcoline (PC)-based liposome
suspensions were purchased from Clodronateliposomes (Netherlands) and were
prepared as previously reported64.
IC50 determination in Aspergillus fumigatus. The A. fumigatus (strain CEA10,
source: FGSC A1163) was grown on Vogel’s medium at 37 C for 5 days before
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the spores (conidia) were harvested. Peptides 4–8 were incubated at different
concentrations with A. fumigatus conidia to reach a ﬁnal volume of 100 ml per well.
The ﬁnal conidia concentration was 5 105 cellsml 1 in 10% Vogel’s medium.
After 24 h incubation at 37 C in 96 well-plates, fungal growth was determined by
measuring OD610nm in a spectrophotometer. IC50 values were determined using
four parameter logistic regression. Data is represented as means±s.e.m from at
least three independent experiments with n¼ 3.
Cell culture of fungal strains. Neurospora crassa (strain 74-OR23-1VA, source:
FGSC 2489) was grown on standard Vogel’s agar (Vogel, 1956) at 25 C under
constant artiﬁcial light for 5 days. Conidia were collected using sterile dH2O and
then diluted in 20% Vogel’s liquid medium for imaging. F. oxysporum (strain 4287,
source: FGSC 9935) was grown in liquid potato dextrose broth (PDB) at 28 C with
shaking. Conidia were re-suspended in 20% Vogel’s liquid medium and imaged
after incubation for 12 h at 30 C. Can. albicans (strain SC5314, source: ATCC
MYA-2876) was grown on yeast peptone dextrose liquid medium at 30 C for 12 h
with shaking and then diluted using minimal medium (0.7% yeast nitrogen base
plus 2% glucose) before imaging. Cry. neoformans (strain H99, source: FGSC 9487)
was grown on yeast peptone dextrose agar at 30 C for 3 days. To collect the cells
for imaging, a single colony 1-2mm in diameter was re-suspended in PBS and
washed once with fresh PBS before imaging.
In vitro measurements of antimicrobial activity. P. aeruginosa (ATCC 47085),
K. pneumoniae (ATCC BAA1706) and E. coli (ATCC 25922) were grown on
Lysogeny Broth (LB) agar plates and stored at 4 C. For assays, a single colony of
bacteria was taken into 10mL liquid broth and incubated at 37 C for 16 h.
Cultures were centrifuged at 4,000 r.p.m. for 5min and the pellet was re-suspended
in 1ml of fresh PBS and washed three times. Cultures were reconstituted to 1.0
OD595 nm, then diluted 1:1,000 and incubated with compounds 4–8 at the indicated
concentrations (that is, concentrations matching the IC50 values in A. fumigatus for
all compounds, except for compounds 3 and 5a where a top concentration of
20mM was used). Cell viability was monitored over 16 h by measuring OD600 nm in
a spectrophotometer. Data is represented as % of cell viability as means from at
least two independent experiments with n¼ 3.
Determination of haemolytic activity. Erythrocytes were isolated from freshly
drawn, anticoagulated human blood and diluted in PBS (1:5). An amount of 50 ml
of erythrocyte suspension was added to 50 ml of compounds 4–8 at the indicated
concentrations (that is, concentrations matching the IC50 values in A. fumigatus for
all compounds, except for compounds 3 and 5a where a top concentration of
20mM was used). 0.2% Triton X-100 was used as positive control and PBS as
negative control. The plate was incubated at 37 C for 1 h, each well was diluted
with 150 ml of PBS and the plate was centrifuged at 1,200g for 15min. A total of
100ml of the supernatant from each well was transferred to a fresh plate, and the
absorbance at 350 nm was measured in a microplate reader. Data is represented as
% of cell viability as means from three independent experiments with n¼ 3.
Confocal microscopy of Aspergillus fumigatus and human cells. Human lung
A549 epithelial cells (ATCC CCL-185) were grown using DMEM supplemented
with 10% fetal bovine serum (FBS), antibiotics (100Uml 1 penicillin and
100mgml 1 streptomycin) and 2mM L-glutamine in a humidiﬁed atmosphere at
37 C with 5% CO2. A549 cells were regularly passaged in T-75 cell culture ﬂasks.
A. fumigatus was grown on standard Vogel’s agar at 37 C for 5 days. Conidia were
collected using 0.05% Tween 80, re-suspended in 20% Vogel’s liquid medium and
incubated for 12 h at 25 C. For co-cultures, human lung epithelial cells were plated
on glass chamber slides Lab-Tek II (Nunc) 2 days before imaging and incubated for
16 h with A. fumigatus conidia reaching 75–90% conﬂuence on the day of the
experiment. For imaging experiments, cells were incubated for 15min at 37 C with
compounds 5–8 (5 mM for compounds 5–7 and 2 mM for compound 8) and imaged
without washing in phenol red-free DMEM under a Zeiss LSM 510 META
ﬂuorescence confocal microscope equipped with a live cell imaging stage.
Fluorescence and bright-ﬁeld images were acquired using  40 or  63 oil
objectives. Fluorescent probes were excited with 488 nm (compounds 5–8) or
543 nm (Syto82) lasers. Confocal microscopy images were analysed and processed
with ImageJ. Quantitative analysis of mean ﬂuorescence intensities in competition
experiments was performed with Imaris by calculating the mean intensity of each
hyphae as independent regions of interests. For competition assays, all images were
acquired and analysed using exactly the same conditions.
Chemical stability in human bronchoalveolar lavages. Peptides 5 and 8 (20 mM)
were dissolved in human bronchoalveolar lavage samples (total volume: 100 ml) and
incubated at 37 C for the indicated times. Samples were injected into an
high-performance liquid chromatography Agilent 1100 separations module
connected to a UV detector with a Discovery C18 column (5mm, 4.6 50mm).
Matrix-assisted laser desorption/ionization data was recorded on a Bruker Ultraﬂex
mass spectrometer using sinapinic acid as the matrix.
Multi-photon imaging in ex vivo human tissue. Ex vivo human lung tissue
experiments were approved by the NHS Lothian Tissue Governance Committee
and Regional Ethics Committee (REC reference: ref. 13/ES/0126). Human lung
tissue was obtained from the periphery (non-cancerous) region of patients
undergoing resection for lung cancer. A 1 cm3 tissue was inﬂated with optimum
cutting temperature formulation and stored at  80 C. Embedded tissue was
cryosectioned at 10mm intervals and ﬁxed onto glass slides for imaging.
RFP-expressing A. fumigatus conidia were grown overnight at 37 C the day before
the experiments and incubated with human lung tissue sections for 2–3 h before
imaging. For multi-photon imaging experiments, the cyclic peptide 8 was used at a
concentration of 5 mM. A custom-built multi-photon microscope was used to
acquire second harmonic generation (SHG) and two-photon ﬂuorescence images.
Brieﬂy, a picoEmerald (APE) laser provided both a tunable pump laser
(720–990 nm, 7 ps, 80MHz repetition rate) and a spatially overlapped Stokes laser
(1064 nm, 5–6 ps and 80MHz repetition rate). GFP two-photon ﬂuorescence
signals were ﬁltered using the following series of ﬁlters: FF520-Di02, FF483/
639-Di01 and ET500/40m. RFP two-photon ﬂuorescence signals were ﬁltered using
FF520-Di02, FF757-Di01 and FF01-609/181, and SHG signals were ﬁltered using
FF520-Di02, FF483/639-Di01 and FF01-466/40. Fluorescence lifetime images were
acquired by connecting the relevant detector to a PicoHarp 300 (Picoquant, Berlin)
and conﬁguring the PMT for photon counting mode for TCSPC-FLIM. SHG and
GFP images were taken with the laser tuned to 950 nm and RFP images were
recorded using a 1,064 nm laser. Lifetime images were recorded at 20mW with a
10 ms pixel dwell using the SymPhoTime software (Picoquant). All images were
analysed and processed using ImageJ.
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